Marel stock reaches a 52-week low as targets stay higher

Marel stock reached a 52-week low of USD 104.36 on October 7, 2026, while JBT Marel Corporation was last at USD 104.6460 on the NYSE. The market value stood at USD 5.4 billion, giving investors a fresh measure of the pressure on the food-processing technology group.

Stock reaches a new low

MarketBeat reported that the stock traded as low as USD 104.36 and last traded at USD 104.6460, with volume of 220,245 shares. The same report placed the previous close at USD 108.69, making the latest market level a central point for the current debate around execution and valuation.

The pressure follows a mixed second quarter. According to JBT Marel, Q2 2026 revenue was USD 981.0 million, while adjusted EBITDA margin was 17.1 percent and backlog reached USD 1.54 billion.

Revenue missed the estimate

JBT Marel also reported adjusted EPS of USD 1.95 for Q2 2026, below the USD 2.02 consensus cited by MarketBeat. The revenue figure also fell short of the USD 988.4 million estimate, a comparison that helps explain why the stock is trading near its yearly low despite continued order activity.

The company said orders exceeded USD 1 billion for the third consecutive quarter and maintained its full-year 2026 outlook. Its Q2 2026 net income was USD 28.0 million, compared with USD 45.0 million in Q1 2026, according to the company investor-relations page.

Consensus target stays above price

MarketBeat puts the consensus rating at Moderate Buy, based on five Buy ratings and two Hold ratings, with an average target price of USD 165.20. That target lies 57.9 percent above the USD 104.6460 last traded price.

Analyst views remain divided on the integration story. Barclays initiated coverage with an Overweight rating and a USD 150.00 target on September 8, 2026, while Robert W. Baird cut its target from USD 188.00 to USD 171.00 on September 24, 2026, according to MarketBeat.

JBT Marel stock stays under pressure

Marel stock was last at USD 104.6460 on the NYSE on October 7, 2026, after touching USD 104.36. The next market test is whether the USD 1.54 billion backlog and orders above USD 1 billion can translate into the margin improvement outlined by management.